1Urata A,Nishimura H,Ganten D,et al.Angiotensin-converting enzyme-independent pathways of angiotensin Ⅱ formation in human tissues and cardiovascular disease.Blood Pression,1991,2:22-28.
2Regitz ZV,Auch SW,Neuss M,et al.Regulation of the angiotensin receptors subtype in cell cultures animal models and human disease.Eur Heart,1994,15:92-97.
3Kanano H,Do YS,Kanano Y,et al.Angiotensin Ⅱ has multiple profibrotic effects in humans cardiac fibroblasts.Circulation,2000,101 (10):1130-1137.
4Cox DA,Cohe ML.Effect of oxidized low-density lipoprotein on vascular contraction and relaxation:clinical and pharmacological implication in atherosclerosis.Pharmacol Rev,1996,48:3-19.
5Mcmullen JR,Giboson KL,Lumbers ER.Selective downregulation in of AT2 receptor in uterine ateries from pregent ewes given 24-h intravenous infusion of angiotensin Ⅱ.Regul Peptides,1999,99:119-129.
6Matsumoto T,Ozono R.Type 2 angiotensin Ⅱ receptor is downregulated in cardiomyocyte of patients with heart failure.Cardiovas Res,2005,46:73-81.
7De Gasparo M,Catt KJ,Inagami I,et al.International Union of pharmacology.the angiotensin Ⅱ receptor.Cardiovas Res,2004,52,415-472.
8Nora EH,Munzenmaier DH,Hansen-smith FM.Localization of the Ang Ⅱ type 2 receptor in the microcirculation of skeletal muscle.Am J Physiol,1998,275:H1395-1403.
9Akishita M,Iwai M,Wu L.Inhibitor effect of angiotensin Ⅱtype 2 receptor on coronary arterial remodeling after aortic banding inmice.Circulation,2000,102:1684-1689.
10Wu L,Iwai M,Nakagami H.Effect of angiotensin Ⅱ type 1bloacksde on cardic remodeling in angiotensin Ⅱ type 2 receptor null mice.Atherosclerosis Thrombosis Vas Biol,2002,22:49-54.
